Literature DB >> 25565326

Health-related quality of life in lung cancer survivors: Latent class and latent transition analysis.

Kelly M Kenzik1, Michelle Y Martin, Mona N Fouad, Maria Pisu.   

Abstract

BACKGROUND: Health-related quality of life (HRQOL) heterogeneity among cancer survivors may mask subgroups (classes) with different limitations and long-term outcomes. The authors determined the HRQOL classes that exist among lung cancer survivors, examined transitions among those classes over time, and compared survival outcomes of patients according to the classes present in the initial phase of care.
METHODS: Lung cancer survivors in the Cancer Care Outcomes Research and Surveillance Consortium completed EuroQol 5-domain quality-of-life questionnaires 4.8 months (initial phase) and >1 year (survivorship phase) after diagnosis (n = 1396). Latent class analysis and latent transition analysis were used to determine HRQOL classes and transitions across time. Correlates of class membership were tested using multinomial logistic regression. Kaplan-Meier and Cox regression analyses were used to compare survival across class membership.
RESULTS: Latent class analysis identified 4 classes at diagnosis and follow-up: 1) poor HRQOL, 2) pain-dominant impairment, 3) mobility/usual activities impairment, and 4) good HRQOL. Probabilities of remaining in the same class were .87, .85, .82, and .73 for classes 4, 1, 3, and 2, respectively. Younger age, lower income, lower education, comorbidities, and a history of depression/emotional problems were associated with a greater likelihood of being in classes 1, 2, or 3 at follow-up. Patients in classes 1 and 3 had significantly lower median survival estimates than patients in class 4 (4.8 years, 3.8 years, and 5.5 years, respectively; P < .001).
CONCLUSIONS: Examining the heterogeneity of HRQOL in lung cancer populations allows the identification of classes with different limitations and long-term outcomes and, thus, guides tailored and patient-centered provision of supportive care.
© 2015 American Cancer Society.

Entities:  

Keywords:  health-related quality of life; latent class; lung cancer; survivor; transition

Mesh:

Year:  2015        PMID: 25565326      PMCID: PMC4409523          DOI: 10.1002/cncr.29232

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

Review 3.  Trial-related quality of life: using quality-of-life assessment to distinguish among cancer therapies.

Authors:  C C Gotay
Journal:  J Natl Cancer Inst Monogr       Date:  1996

4.  Do patients with lung cancer benefit from physical exercise?

Authors:  Andreas H Andersen; Anders Vinther; Lise-Lotte Poulsen; Anders Mellemgaard
Journal:  Acta Oncol       Date:  2011-02       Impact factor: 4.089

5.  Health-related quality of life in patients surviving non-small cell lung cancer.

Authors:  Janneke P C Grutters; Manuela A Joore; Erwin M Wiegman; Johannes A Langendijk; Dirk de Ruysscher; Monique Hochstenbag; Anita Botterweck; Philippe Lambin; Madelon Pijls-Johannesma
Journal:  Thorax       Date:  2010-10       Impact factor: 9.139

6.  Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes.

Authors:  B Muthén; L K Muthén
Journal:  Alcohol Clin Exp Res       Date:  2000-06       Impact factor: 3.455

Review 7.  Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials.

Authors:  Andrew Bottomley; Fabio Efficace; Ronald Thomas; Veerle Vanvoorden; Sam H Ahmedzai
Journal:  J Clin Oncol       Date:  2003-08-01       Impact factor: 44.544

8.  US norms for six generic health-related quality-of-life indexes from the National Health Measurement study.

Authors:  Dennis G Fryback; Nancy Cross Dunham; Mari Palta; Janel Hanmer; Jennifer Buechner; Dasha Cherepanov; Shani A Herrington; Ron D Hays; Robert M Kaplan; Theodore G Ganiats; David Feeny; Paul Kind
Journal:  Med Care       Date:  2007-12       Impact factor: 2.983

Review 9.  A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung cancer.

Authors:  Tawee Tanvetyanon; Heloisa P Soares; Benjamin Djulbegovic; Paul B Jacobsen; Gerold Bepler
Journal:  J Thorac Oncol       Date:  2007-12       Impact factor: 15.609

10.  Addressing ceiling effects in health status measures: a comparison of techniques applied to measures for people with HIV disease.

Authors:  I-Chan Huang; Constantine Frangakis; Mark J Atkinson; Richard J Willke; Walter L Leite; W Bruce Vogel; Albert W Wu
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

View more
  11 in total

1.  Examining health-related quality of life patterns in women with breast cancer.

Authors:  Laura C Pinheiro; Xianming Tan; Andrew F Olshan; Stephanie B Wheeler; Katherine E Reeder-Hayes; Cleo A Samuel; Bryce B Reeve
Journal:  Qual Life Res       Date:  2017-02-28       Impact factor: 4.147

2.  Marfan Syndrome and Quality of Life in the GenTAC Registry.

Authors:  Judith Z Goldfinger; Liliana R Preiss; Richard B Devereux; Mary J Roman; Tabitha P Hendershot; Barbara L Kroner; Kim A Eagle
Journal:  J Am Coll Cardiol       Date:  2017-06-13       Impact factor: 24.094

3.  The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.

Authors:  Kenichi Yoshida; Hidenori Fukuoka; Ryusaku Matsumoto; Hironori Bando; Kentaro Suda; Hitoshi Nishizawa; Genzo Iguchi; Wataru Ogawa; Susan M Webb; Yutaka Takahashi
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

4.  Health-Related Quality of Life Among Homeless Smokers: Risk and Protective Factors of Latent Class Membership.

Authors:  Lorra Garey; Lorraine R Reitzel; Julie Neisler; Darla E Kendzor; Michael J Zvolensky; Clayton Neighbors; Daphne C Hernandez; Michael S Businelle
Journal:  Behav Med       Date:  2018-05-14       Impact factor: 3.104

5.  Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: A latent transition analysis.

Authors:  Caroline King; Christina Nicolaidis; P Todd Korthuis; Kelsey C Priest; Honora Englander
Journal:  J Subst Abuse Treat       Date:  2020-08-24

6.  Health-Related Quality of Life Declines Over 3 Years for Congenital Heart Disease Survivors.

Authors:  Jamie L Jackson; Jennifer DeSalvo; Carine E Leslie; Joseph R Rausch
Journal:  J Cardiovasc Nurs       Date:  2021 Mar-Apr 01       Impact factor: 2.083

7.  A non-compensatory analysis of quality of life in breast cancer survivors using multivariate hidden Markov modeling.

Authors:  Edward H Ip; Beverly J Levine; Nancy E Avis
Journal:  Qual Life Res       Date:  2020-10-03       Impact factor: 3.440

8.  Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.

Authors:  Wahyu Wulaningsih; Mariam Vahdaninia; Mark Rowley; Lars Holmberg; Hans Garmo; Håkan Malmstrom; Mats Lambe; Niklas Hammar; Göran Walldius; Ingmar Jungner; Anthonius C Coolen; Mieke Van Hemelrijck
Journal:  BMC Cancer       Date:  2015-11-17       Impact factor: 4.430

9.  Longitudinal Model Building Using Latent Transition Analysis: An Example Using School Bullying Data.

Authors:  Ji Hoon Ryoo; Cixin Wang; Susan M Swearer; Michael Hull; Dingjing Shi
Journal:  Front Psychol       Date:  2018-05-08

10.  Applying the thresholds for clinical importance for fourteen key domains of the EORTC QLQ-C30: a latent class analysis of cancer survivors.

Authors:  Laura Keaver; Christopher McLaughlin
Journal:  Support Care Cancer       Date:  2021-06-25       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.